2022
DOI: 10.3389/fonc.2022.843268
|View full text |Cite
|
Sign up to set email alerts
|

Case report: Fetal cervical immature teratoma and copy number variations

Abstract: Fetal cervical teratoma is a rare congenital neck tumor. Here, we report a case of a fetus with an anterior solid neck tumor that was confirmed to have an immature teratoma by histology. A duplication was found at chromosome 14q24.1-q24.3 of the fetus in chromosome microarray (CMA) and whole exome sequencing (WES), which was a copy number variation (CNV) and a probably new-onset. Ultrasound coupled with magnetic resonance imaging (MRI) can be considered to be a relatively reliable diagnostic tool, whereas ex-u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…More recently, Olfe et al have demonstrated CTLA-4 insufficiency due to a novel CTLA-4 deletion using ClinCNV ( German and Stephan, 2019 ; Olfe et al, 2023 ), further highlighting the synergy of CNV calling with WES analysis. Beyond the scope of autoimmune diseases, NGS techniques have also been extensively utilized in identifying causal variants (including CNVs) contributing to cancer ( van Dijk et al, 2014 ; Papp et al, 2021 ; Satam et al, 2023 ), congenital ( Lai et al, 2021 ; Li et al, 2022 ; Liu et al, 2022 ; Wang et al, 2022 ; Wu et al, 2022 ; Refeat et al, 2023 ), cardiovascular ( Hu et al, 2023 ) and hematological diseases ( Hassan et al, 2023 ).…”
Section: Discussionmentioning
confidence: 99%
“…More recently, Olfe et al have demonstrated CTLA-4 insufficiency due to a novel CTLA-4 deletion using ClinCNV ( German and Stephan, 2019 ; Olfe et al, 2023 ), further highlighting the synergy of CNV calling with WES analysis. Beyond the scope of autoimmune diseases, NGS techniques have also been extensively utilized in identifying causal variants (including CNVs) contributing to cancer ( van Dijk et al, 2014 ; Papp et al, 2021 ; Satam et al, 2023 ), congenital ( Lai et al, 2021 ; Li et al, 2022 ; Liu et al, 2022 ; Wang et al, 2022 ; Wu et al, 2022 ; Refeat et al, 2023 ), cardiovascular ( Hu et al, 2023 ) and hematological diseases ( Hassan et al, 2023 ).…”
Section: Discussionmentioning
confidence: 99%